Skip to main content
Top
Published in: Immunologic Research 6/2022

Open Access 14-09-2022 | Multiple Myeloma | Original Article

A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma

Authors: Laura Caponi, Alice Botti, Nadia Romiti, Aldo Paolicchi, Maria Franzini

Published in: Immunologic Research | Issue 6/2022

Login to get access

Abstract

Antibody light chains are synthesized in excess by plasma cells, and this excess can be secreted into biological fluids as dimers or monomers in various proportions. Structural differences between monomers or dimers of free light chains (FLC) can affect their biological functions and possibly their pathogenicity. They also may exhibit differential immune reactivity, perhaps explaining discrepant quantifications when measured by different immunoreagents. Having purified FLC monomers and dimers available can be useful for studying their properties. Here we propose a simple preparatory procedure to purify FLC monomers and dimers from urine samples of patients with plasma cell disorders. Two representative urine samples containing lambda or kappa FLC were loaded into a nonreducing sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). The gel strips containing separate monomers and dimers were excised, electroeluted, and the FLC recovered. The FLC were recovered from SDS-PAGE gel in sufficient amounts to be quantified by UV and two automated nephelometric assays immunochemical. The procedure was found to be simple, reproducible, and with a high yield, thus offering the opportunity to compare different assays. Not all urine samples are suitable for this procedure, but this approach allows for the purification of FLC monomers and dimers from many selected urine samples which maintain their oligomeric organization.
Literature
9.
go back to reference Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121–7. https://doi.org/10.1038/leu.2010.60.CrossRefPubMedPubMedCentral Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121–7. https://​doi.​org/​10.​1038/​leu.​2010.​60.CrossRefPubMedPubMedCentral
14.
go back to reference Palladini G, Jaccard A, Milani P, Lavergne D, Foli A, Bender S, et al. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Clin Chem Lab Med. 2017;55:1734–43. https://doi.org/10.1515/cclm-2016-1024.CrossRefPubMed Palladini G, Jaccard A, Milani P, Lavergne D, Foli A, Bender S, et al. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Clin Chem Lab Med. 2017;55:1734–43. https://​doi.​org/​10.​1515/​cclm-2016-1024.CrossRefPubMed
20.
go back to reference Kaplan B, Ramirez-Alvarado M, Dispenzieri A, Zeldenrust SR, Leung N, Livneh A, et al. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Clin Chem Lab Med. 2008;46:335–41. https://doi.org/10.1515/CCLM.2008.068.CrossRefPubMed Kaplan B, Ramirez-Alvarado M, Dispenzieri A, Zeldenrust SR, Leung N, Livneh A, et al. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Clin Chem Lab Med. 2008;46:335–41. https://​doi.​org/​10.​1515/​CCLM.​2008.​068.CrossRefPubMed
Metadata
Title
A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma
Authors
Laura Caponi
Alice Botti
Nadia Romiti
Aldo Paolicchi
Maria Franzini
Publication date
14-09-2022
Publisher
Springer US
Published in
Immunologic Research / Issue 6/2022
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-022-09314-8

Other articles of this Issue 6/2022

Immunologic Research 6/2022 Go to the issue